Quote: Mild Rover "In response to ZZB.
I think we could have planned a lot better for Brexit. But I understand the reasons (good, bad and inevitable) why we didn’t. Ultimately, people weigh the costs and benefits differently and we all made up our minds a long time ago.
The AZ-vaccine nervousness within the EU seemed very much to come at the national level. The EU regulatory body (the EMA) approved the AZ vaccine in all age groups and didn’t suspend approval in response the reports of thromboembolic events. I assume that was national health technology assessment agencies exercising an, imo excessive in the circumstances, degree of caution. Just as England has NICE (and Scotland has the SMA and Wales has the AWMSG), France has HAS and Italy has AIFA etc. The approval of all these vaccines was ‘expedited’, so I could kind of get a slightly wary reaction in countries that haven’t been hard hit by COVID. Where they’ve had it nearly as bad as us, it seems perverse to me. But these are independent, sovereign countries and they can make their own decisions.
I should have Googled commercial banking.'"
There was a couple of cases in Norway - but no correlation to AZ jab was ever made yet Germany, France etc jumped on the bandwagon - why? There were known side effects of the Pfizer jab which were far more prevalent than those of AZ jab - anaphylactic shock, respiratory problem, facial nerve paralysis yet nothing - why AZ and not Pfizer - the logic doesn't stack up.
